Heath Fletcher

In this conversation, Michael Friend, Founder and CEO of the Minority Coalition for Precision Medicine, discusses the critical role of precision medicine and CRISPR technology in addressing health disparities, particularly in minority communities. He shares his personal journey, the challenges faced by individuals with sickle cell disease, and the importance of building trust in healthcare. The conversation emphasizes the need for community engagement, youth involvement, and advocacy to drive change in the healthcare landscape. Chapters: 00:00 Introduction to Precision Medicine and CRISPR 03:00 Understanding Sickle Cell Disease and Its Challenges 06:00 The Role of CRISPR in Healthcare 09:02 The Importance of Trust in Healthcare for Minorities 11:59 The Coalition's Mission and Community Engagement 14:56 Overcoming Skepticism Around Precision Medicine 18:01 The Tipping Point for CRISPR and Public Awareness 21:12 Future of Precision Medicine and Business Models 23:49 Advocacy and Personal Motivation 27:03 Engaging Youth in Healthcare Conversations 30:05 Advice for Aspiring Change-Makers 33:11 Conclusion and Future Outlook Guest Information:Guest's Name: Michael FriendGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/michael-friend-/Company / Affiliation: Minority Coalition for Precision MedicineGuest's Bio: Michael Friend is a U.S. veteran and founder of the Minority Coalition for Precision Medicine (MCPM), dedicated to ensuring precision medicine serves all communities, not just the privileged few. Inspired by his East Baltimore roots and the legacy of Henrietta Lacks, Michael fights for health equity through coalition-building, youth education, and advocacy in areas like CRISPR, sickle cell disease, and microbiome science. His work is a mission of justice, remembrance, and redemption, amplifying voices long ignored in healthcare.Takeaways:Michael Friend is the CEO of the Minority Coalition for Precision Medicine.The coalition aims to reduce health disparities in minority communities.Sickle cell disease is a painful and complex condition.CRISPR technology has the potential to reshape healthcare.Building trust in healthcare is crucial for minority communities.Community engagement is essential for awareness and education.Skepticism around precision medicine exists but is changing.Youth involvement is vital for the future of healthcare.Private-public partnerships are necessary for innovation.Advocacy and personal motivation drive change in healthcare.

In this episode of The Healthy Enterprise, Trace Voshell, Chief Revenue Officer at GoGoMeds, shares his journey from baseball player to pharmacy leadership. He discusses the challenges of healthcare costs, innovations in medication access, telemedicine, and custom pharmacy solutions, while offering insights on leadership, team collaboration, and making medications more affordable for employers and employees. Chapters: 00:00 Introduction to GoGoMeds and Trace's Journey 02:57 Understanding Pharmacy Operations and Patient Care 05:54 The Challenges of Healthcare Costs 09:02 Innovations in Medication Access and Employer Benefits 11:52 Telemedicine and Custom Pharmacy Solutions 14:49 Transitioning to GoGoMeds and Leadership Style 24:03 The Drive to Win: A Personal Philosophy 25:04 Documentary Insights: Uncovering Healthcare Costs 28:07 Marketing Strategies: Outsourcing for Growth 32:18 Sales Team Dynamics: Growth and Strategy 34:32 The Balance of Aggression and Patience in Sales 38:03 Building a Winning Corporate Culture 43:13 AI in Business: Balancing Automation and Personal Touch 45:13 Final Thoughts and Future Connections Guest Information:Guest's Name:Trace VoshellGuest's Title/Position: Chief Revenue OfficerGuest's Linkedin: https://www.linkedin.com/in/trace-voshell-34040b7a/Company / Affiliation: GoGoMeds https://gogomeds.com/GoGoClient/homeGuest's Bio: Trace Voshell is the Chief Revenue Officer of GoGoMeds, a company transforming pharmacy pricing by moving beyond traditional PBM models. After a decade in a large PBM-owned pharmacy, Trace shifted to the cash-pay side to make medications more affordable through a transparent, cost-plus pricing model. GoGoMeds empowers employers, physicians, and digital health companies to deliver medicine fairly, save money, and put patients first. Takeaways:Trace Voshell transitioned from a baseball career to pharmacy.GoGoMeds aims to transform patient access to medications.Healthcare costs can be overwhelming for patients.GoGoMeds offers significant savings on generic medications.Employers can benefit from offering $0 medications to employees.Telemedicine is a growing area for GoGoMeds.Custom pharmacy solutions enhance patient care.Trace's personal experience with cancer informs his work.Leadership involves being hands-on and empathetic.Failures are part of the journey to success.  I like to win, don't care about recognition.The documentary 'It's Not Personal, It's Just Healthcare' uncovers hidden costs.Go Go Meds is a solution in the pharmacy space.I was one of the producers of the documentary.We needed to enhance our marketing efforts.You can't just have one marketing piece for all verticals.Aggression and patience are key in sales.Culture is crucial for employee motivation.You have to remain a person in sales interactions.We're changing the pharmacy landscape for affordability.

In this heartfelt conversation, Raymond Rodriguez-Torres shares his journey as the CEO of ALC Home Health and the founder of the Live Like Bella Foundation, which supports families affected by childhood cancer. He recounts the challenges faced when his daughter Bella was diagnosed with cancer and how her spirit inspired a movement to help others. The discussion highlights the foundation's significant contributions to pediatric cancer research and the support services it provides to families in need. In this conversation, Raymond shares his journey of turning personal tragedy into a mission to help others through the Live Like Bella organization. He emphasizes the importance of living joyfully and fearlessly, serving others during difficult times, and the critical need for accurate data in pediatric cancer research. The discussion also highlights innovations in treatment and the transition to home health care, along with valuable leadership lessons about trust and purpose in work. Chapters: 00:00 Introduction to Raymond Rodriguez-Torres and His Journey 02:21 The Impact of Bella's Illness on Family and Community 07:12 Navigating Professional Life Amidst Personal Crisis 11:37 The Mission and Achievements of Live Like Bella Foundation 16:31 In-Treatment and Memorial Support Services 23:36 Living Like Bella: A Legacy of Joy and Fearlessness 25:05 Facing Tragedy: Finding Purpose in Adversity 25:42 The State of Pediatric Cancer: Data and Awareness 29:06 The Importance of Accurate Data in Childhood Cancer 32:08 Innovations in Pediatric Cancer Research 36:36 Transitioning to Home Health Care: A Personal Journey 41:11 Leadership Lessons: Trust and Purpose in Work Guest Information:Guest's Name: Raymond Rodriguez-TorresGuest's Title/Position: ChairmanGuest's Linkedin: https://www.linkedin.com/in/raymond-rodriguez-torres-9820456/Company / Affiliation:  Live Like Bella® Foundation  https://livelikebella.org/ Guest's Bio: Raymond Rodriguez-Torres is a bestselling author, acclaimed keynote speaker, and former executive with global organizations including Sanofi-Aventis, Genentech, and Hoffman-La Roche. A TEDx speaker, his talk Tragedy to Triumph: Live Like Bella ranks #2 worldwide on YouTube. Raymond has led teams of over 150 and managed sales exceeding $300 million. In memory of his daughter Bella, he serves as Chairman of the Live Like Bella® Foundation, which has funded millions for childhood cancer research and supported families in 38 countries. Raymond donates 100% of his book proceeds to pediatric cancer research and charity. A graduate of the University of Florida and Master’s in Management from Oral Roberts University, Raymond is also a licensed Master U.S. Coast Guard Captain, a maritime consultant, and a trained life coach. His work has earned him national and international recognition, including being named one of the most influential Hispanic leaders by Univision and one of “Florida’s Heroes” by Gov. Ron DeSantis. Takeaways:Raymond Rodriguez-Torres is the CEO of ALC Home Health and founder of Live Like Bella.The Live Like Bella Foundation has raised over $40 million for childhood cancer research.Bella's illness led to the creation of a movement focused on serving others.The foundation provides financial support for families dealing with childhood cancer.Live Like Bella funds pediatric cancer research through innovative state funding initiatives.The organization pays bills directly to avoid tax implications for families.Memorial support is offered for families who have lost children to cancer.Raymond emphasizes the importance of community support during crises.The foundation operates in 38 countries, providing global assistance.Raymond believes that Bella's life was a gift that continues to inspire others. Live like Bella as a guiding principle in life.Serving others can provide strength during adversity.Finding a purpose can help answer the question of why.Accurate data is crucial in understanding childhood cancer.Childhood cancer should be treated as a chronic illness.Innovative research is leading to breakthroughs in pediatric oncology.Home health care offers better comfort for patients.Trust is essential in leadership and team dynamics.Passion in work leads to fulfillment and success.Every child deserves a chance to fight cancer at home.

In this episode, Laura Lampa, CEO of LML StoryLab Consulting, shares her journey from a scientist to a communication expert in the life sciences sector. She discusses the importance of effective communication in science, her transition to entrepreneurship, and the challenges of being a solopreneur. Laura emphasizes the significance of networking, leveraging AI in her work, and maintaining a work-life balance. She also provides valuable advice for aspiring entrepreneurs and shares her vision for the future of her business. Chapters: 00:00 Introduction to Laura Lampa and LML StoryLab 02:54 Journey from Science to Communication 05:55 The Transition to Entrepreneurship 09:02 Challenges of Solopreneurship 12:01 Networking and Building Relationships 15:00 Vision for the Future of LML StoryLab 18:11 Leveraging AI in Communication 20:57 Advice for Aspiring Entrepreneurs 23:54 Conclusion and Key Takeaways Guest Information:Guest's Name:Laura Lampa Guest's Title/Position: Founder and CEOGuest's Linkedin: https://www.linkedin.com/in/lauralampa/Company / Affiliation: LML StoryLab Consulting https://lmlstorylab.com/homeGuest's Bio: Laura Lampa is the Founder and CEO of LML StoryLab Consulting, where she helps mission-driven companies in agriculture, fermentation, and sustainability tell compelling stories that inspire action. With over 18 years of experience spanning global organizations and startups—including Monsanto, Kaiser Permanente, Bayer Crop Science, and Ginkgo Bioworks—Laura brings a unique blend of scientific expertise and communications leadership. A former bench scientist turned strategist, she specializes in science communication, change management, and stakeholder engagement, empowering organizations to connect authentically and drive meaningful impact.Takeaways:Laura Lampa transitioned from a scientist to a communication expert.Effective communication can unlock conversations and connections.Networking is crucial for building relationships and finding clients.AI can be a strategic partner in writing and communication.Time management is a significant challenge for solopreneurs.Maintaining professional connections helps avoid loneliness.It's important to know your limits as a solopreneur.You can develop tools and templates for clients to use independently.Showing up consistently builds credibility and trust.Entrepreneurship requires a willingness to take risks and embrace challenges.

In this episode of The Healthy Enterprise, host Brian Newsom discusses his journey in the biotechnology field, focusing on his role as CEO of Carrigent, a company specializing in cell and gene therapy. He elaborates on the innovative vector technology being developed for targeted payload delivery, the challenges of fundraising in the current market, and the integration of AI to enhance operational efficiency. Brian also shares insights into the importance of strategic partnerships and the ultimate goal of bringing therapeutic solutions to patients. In this conversation, the speaker discusses the importance of building long-term relationships in healthcare, particularly in the context of gene therapy. They share insights on leadership styles, emphasizing trust and autonomy within teams. The challenges of being a founder are explored, along with the need for inspiration and motivation in tough times. The discussion also touches on the intersection of science fiction and current scientific advancements, future trends in healthcare, and advice for aspiring professionals in the field. Chapters00:00 Introduction to Cell and Gene Therapy Innovations03:04 Exploring Vector Technology and Its Applications05:59 Brian Newsom's Journey: From Science to Business09:08 Leveraging AI and Technology in Biotech11:59 Navigating Fundraising Challenges in Biotech14:49 Strategic Partnerships and Market Positioning22:12 Building Long-Term Relationships in Healthcare23:27 Leadership Style and Team Dynamics26:00 The Challenges of Foundership28:32 Finding Inspiration and Motivation31:12 The Intersection of Science Fiction and Reality33:03 Future Trends in Healthcare35:34 Advice for Aspiring Professionals37:17 Navigating Tough Times in the Industry Guest Information:Guest's Name: Brian NewsomGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/brian-newsom/Company / Affiliation:  Carrigent https://carrigent.com/Guest's Bio: Brian Newsom is the founding CEO of the vector technology company, Carrigent, as well as the VP of Business Development for the cell therapy CDMO, Theragent. Prior to this, Brian spent six years at KBI Biopharma and almost a decade at Thermo Fisher Scientific (and legacy companies) in business development. Brian’s technical background includes posts as Head of R&D at Opexa Therapeutics and five years at Baylor College of Medicine, Center for Cell and Gene Therapy. Brian began his career in cell therapy at Aastrom Biosciences, one of the industries pioneering companies, in 1992. Brian received his degree in Microbiology from Texas Tech University and an MBA from Texas A&M University. Takeaways:Brian Newsom is the CEO of Carrigent, focusing on cell and gene therapy.Carrigent is developing a next-generation payload delivery system.The company is exploring applications in oncology, metabolic, and neurodegenerative diseases.Brian transitioned from a scientific role to business development to have a broader impact.AI is being leveraged to create efficiencies in biotech operations.Fundraising in biotech is currently challenging due to market conditions.Strategic partnerships are essential for asset development and exposure.The ultimate goal is to partner with pharma and biotech for therapeutic development.Brian's diverse background provides a unique perspective in the industry.The end users of their technology will be pharma and biotech companies. Building long-term relationships is crucial in healthcare.Leadership involves trusting your team to do their jobs.Founders often struggle to let go of their vision.Inspiration can come from various sources, including literature.Science fiction often predicts future scientific advancements.Early diagnostics are essential for effective treatment.The healthcare industry is evolving with new therapies.Resilience is key in navigating industry challenges.Patient care should be the primary motivation for professionals.The future of healthcare will focus on curing chronic diseases.

In this episode of The Healthy Enterprise, Brent Lucas, CEO of Envoy Medical, shares his journey from lawyer to medical device executive and the evolution of Envoy’s pioneering hearing technologies. He discusses the challenges of leading innovation through clinical trials, navigating the shift from private to public, and the importance of community engagement. Brent also reflects on leadership lessons from sports, family entrepreneurship, and the power of patient stories in driving impact. Chapters: 00:00 Introduction to Envoy Medical and Brent Lucas 01:01 Brent's Journey in the Hearing Loss Industry 05:03 Transforming Envoy Medical's Product Line 09:04 The Impact of Cochlear Implants on Quality of Life 13:01 Navigating Clinical Trials and Market Readiness 15:10 Transitioning from Lawyer to CEO 18:03 Leadership Challenges and Personal Management 22:07 Family Influence and Entrepreneurial Spirit 23:35 Going Public: A Strategic Decision 24:24 Navigating the Public Market: Opportunities and Challenges 27:39 Community Impact: Building Jobs and Relationships 30:10 Leadership Lessons: From Sports to Business 33:58 Overcoming Obstacles: Personal Growth and Imposter Syndrome 36:19 Innovating with Technology: The Future of Medical Devices 41:41 Marketing Strategy: Organic Growth Through Patient Stories Guest Information:Guest's Name: Brent LucasGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/brent-lucas-envoy/Company / Affiliation: Envoy Medical https://www.envoymedical.com/Guest's Bio: Brent  Lucas is CEO and Board Member of Envoy Medical, an early-stage medical device company pioneering fully implanted hearing solutions, including the Esteem® active middle ear implant and the investigational Acclaim® cochlear implant. A principled medical device executive with a legal background, Brent brings 15+ years of leadership across enterprise functions—spanning strategy, finance, compliance, stakeholder engagement, and product development. Known for his transparent and motivating leadership style, he has guided Envoy through organizational turnaround, fundraising, and global commercialization efforts. With a track record of building inspired teams, streamlining operations, and driving patient-focused innovation, Brent is dedicated to improving quality of life through breakthrough medical technologies.Takeaways:Envoy Medical is a 30-year-old startup focused on hearing loss solutions.Brent Lucas became CEO during a pivotal transformation of the company.The company specializes in fully implanted hearing devices without external components.Cochlear implants can greatly enhance the quality of life for users.Navigating clinical trials is a lengthy but necessary process for product launch.Brent transitioned from a legal background to a leadership role in a medical device company.Effective communication is crucial for leadership success.Family influence played a significant role in Brent's entrepreneurial journey.The decision to go public was strategic for the company's growth.Brent emphasizes trusting instincts in decision-making as a CEO. Going public provides liquidity options for investors and employees.Community engagement is crucial for company culture and job creation.Leadership lessons can be learned from unexpected places, like sports.Imposter syndrome is a common challenge for leaders.Innovating with technology is essential in the medical device industry.Patient demand for fully implanted devices is expected to be high.Organic marketing through patient stories can be powerful.The transition to public markets comes with both opportunities and challenges.Maintaining focus on core products is vital for success.The surgical process for the new device is outpatient and efficient.

In this episode, Stefan Lukianov, founder and CEO of Salve Therapeutics, shares his journey in biotech and the creation of a healthcare app designed to improve patient experiences. He discusses leveraging technology to lower drug development costs—especially for rare diseases—and the role of real-time health data in patient empowerment. Stefan also reflects on challenges such as fundraising, the founder-to-CEO transition, and the importance of mentorship, collaboration, and clear vision in driving innovation within the healthcare industry. Chapters:00:00 Introduction to Salve Therapeutics and Patient Empowerment02:58 The Role of Technology in Drug Development06:00 Innovative Software Solutions for Rare Diseases08:58 Patient Self-Management and Mobile Health Apps12:06 Collaboration and Mentorship in Biotech14:56 Real-Time Health Data and Patient Engagement26:23 The Journey of App Development31:01 Navigating Fundraising and Investor Relations37:17 Transitioning from Founder to CEO44:30 The Importance of Thoughtfulness in Leadership Guest Information:Guest's Name: Stefan LukianovGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/stefan-n-lukianov-3a6862205/Company / Affiliation:  Salve Therapeutics https://www.salvetherapeutics.com/Guest's Bio: Stefan Lukianov is an artist, author, educator, businessman, and scientist with a background in computational bioengineering. He is the founder and CEO of Salve Therapeutics, where he is dedicated to advancing patient care through innovative viral and biologic therapies powered by advanced software solutions. His work centers on patient empowerment, with a focus on leveraging real-time health data and mobile health technologies to improve self-management, independence, and access to care. Beyond his role at Salve, Stefan is a strong advocate for mentorship and collaboration in the biotech industry, aiming to foster innovation, thoughtfulness, and a more patient-centered future for healthcare.Takeaways:Stefan Lukianov is the founder and CEO of Salve Therapeutics.Salve Therapeutics focuses on patient empowerment through technology.The company aims to reduce the cost of drug development for rare diseases.Their software is designed for drug developers to streamline the process.Real-time health data is crucial for patient engagement.Collaboration and mentorship are key in the biotech field.Mobile health apps can enhance patient self-management.The goal is to make healthcare more accessible and efficient.Patient independence is a priority in healthcare innovation.Technology is transforming the way healthcare is delivered.  The app has been in development since spring 2022.It's important to attract users with the app's design and functionality.Fundraising is a complex process that requires careful planning.Transitioning from founder to CEO involves balancing vision with operational realities.Thoughtfulness in decision-making leads to better outcomes.Listening to feedback is crucial for growth as a founder and CEO.Building relationships with potential customers is key to success.The healthcare app industry is heavily regulated, making development challenging.Networking and attending events can lead to valuable connections.Having a clear vision helps in managing investor expectations.

In this episode, Marc Koska shares his journey as a social entrepreneur and healthcare innovator. He discusses creating the K1 auto-disabled syringe, which has saved millions of lives by preventing the spread of blood-borne diseases, and his transition to Apiject to advance healthcare delivery with new injection technologies. Marc also reflects on lessons from biomimicry and product design, the challenges of global health in developing countries, and the importance of firsthand experience, social awareness, and data-driven decision-making in driving meaningful innovation. Chapters: 00:00 Introduction to Marc Koska and His Innovations 05:03 The Birth of the K1 Auto-Disabled Syringe 12:09 Impact of the K1 Syringe on Global Health 17:50 Transition to Apiject and New Innovations 25:03 Future of Healthcare and Injection Devices 26:59 Empowerment Through Creation 29:20 The Birth of Biomimicry 32:12 Social Impact and Empowerment 35:24 Innovations in Design and Technology 39:35 The Journey of Social Entrepreneurship 45:55 Advice for Aspiring Innovators Guest Information:Guest's Name: Marc KoskaGuest's Title/Position: Co-founder and Head of Production DesignGuest's Linkedin: https://www.linkedin.com/in/marc-koska-5761181a/Company / Affiliation: ApiJect https://apiject.com/Guest's Bio: The inventor of the Apiject Platform and its first BFS injection device is Marc Koska, a highly honored “social entrepreneur.” The Prefilled Apiject Injector is designed for simplicity: Just prior to injection, a fill-finished Blow-Fill-Seal container and intramuscular needle hub are push-twisted together by a healthcare professional. Leading Apiject R&D, Marc and his team design drug delivery system prototypes that can reliably serve both advanced and developing markets. Through feedback from patients and healthcare providers, Marc has a deep understanding of customers and in building healthcare partnerships. This feedback is the foundation of Apiject’s Platform to ensure our single-use prefilled injector and future devices meet the needs of all. The Apiject Platform of drug delivery devices is designed to optimize manufacturing, warehousing, and transportation, using advanced technology, deliver cost efficiencies and accelerating time to market, and most importantly, save lives. Takeaways:Marc Koska invented the K1 auto-disabled syringe to prevent disease spread.The K1 syringe has saved approximately 12 million lives.Syringe reuse was a major transmission route for HIV.Marc's journey involved extensive research and learning about syringes.The K1 syringe design was a significant innovation in healthcare.Marc's work has had a profound impact on global health education.Apiject aims to provide safer and more accessible injection devices.The new injection devices are designed for self-administration.Environmental concerns are addressed with new syringe designs.Marc's career reflects a commitment to solving large-scale health problems. Empowerment comes from creating impactful solutions.Biomimicry is a study of nature's designs and interactions.Social entrepreneurship requires understanding the core truth of problems.Technology, like AI and 3D printing, enhances design processes.Traveling and seeing problems firsthand is crucial for entrepreneurs.Data and understanding all viewpoints are essential for success.Innovative design must consider social implications.Creating a supportive team culture is vital for success.Challenging the status quo is necessary for meaningful change.Success in social entrepreneurship requires a combination of passion and practicality.

In this episode of The Healthy Enterprise Podcast, Gautham Pasupuleti, CEO and Co-founder of Biodesign Innovation Labs, shares his journey in the medical device industry and the role of personal experiences in shaping innovation. He discusses challenges in healthcare entrepreneurship, the impact of mentorship and community, and his focus on AI and precision medicine, especially in cancer treatment, offering advice for aspiring entrepreneurs. Chapters:00:00 Introduction to Biodesign Innovation Labs02:47 Innovative Medical Devices for Critical Care05:50 AI and Precision Medicine in Cancer Care08:48 The Journey of Entrepreneurship in Healthcare12:05 Personal Experiences Shaping Innovation14:56 Building a Team and Community Engagement17:51 The Role of Mentorship and Collaboration21:07 Navigating the Healthcare Ecosystem23:56 Advice for Aspiring Innovators29:21 Journey into Medical Device Innovation32:53 Overcoming Personal Tragedy and Professional Challenges35:46 The Importance of Team Dynamics in Medical Innovation39:28 Leadership Lessons from Personal Loss44:37 Future Aspirations in Cancer Treatment and AI48:19 Advice for Aspiring Entrepreneurs Guest Information:Guest's Name: Gautham PasupuletiGuest's Title/Position: Co Founder & CEOGuest's Linkedin:https://www.linkedin.com/in/gautham-pasupuleti-84884054/Company / Affiliation: Biodesign Innovation Labs https://biodesigninnovationlabs.com/Guest's Bio: Gautham Pasupuleti is the CEO and Managing Director of Biodesign Innovation Labs, a Bangalore- and Delaware-based medical device and healthcare company developing innovative and affordable critical care solutions. He leads a multidisciplinary team focused on life-saving technologies, including the patented RespirAID device, which supported hospitals across India during COVID-19. Gautham is a recognized innovator, having received awards such as Forbes India’s Ultimate 120 Pioneers of Change, the CISCO Global Problem Solver Pandemic Response Prize, and the Best Campus Startup Innovation Award from IIT Bombay. Previously, he was a researcher at MIT Media Lab and founded CornealX, an AI-based eye care startup now integrated into Biodesign Innovation Labs. Takeaways:Biodesign Innovation Labs focuses on life-saving medical devices.Respirate is an automated solution for manual ventilation.The company started its journey in 2017 with a focus on critical care.Personal experiences can drive innovation in healthcare.Community engagement is crucial for understanding healthcare needs.Mentorship plays a significant role in entrepreneurial success.AI solutions are being developed for early cancer detection.Building a team with diverse skills is essential for success.Hands-on experience is vital for understanding real-world problems.Workshops and seminars can provide valuable insights and connections. Gautham's journey began with a desire to innovate in medical technology.He collaborated on a VR and AR device for children's eye exams.After his brother's passing, he took on significant responsibilities in their startup.The importance of innovation in medical devices cannot be overstated.Team dynamics and diverse skill sets are crucial for success.Personal experiences can drive motivation to solve meaningful problems.Leadership requires making tough decisions and trusting your instincts.Gautham learned valuable lessons from his brother's mentorship.Resilience and persistence are key traits for entrepreneurs.Networking with experienced individuals can provide valuable insights. 

In this episode of the Healthy Enterprise podcast, Kevin Harris, President of CureMetrix, shares his journey in tech and the co-founding of CureMetrix, a company using AI to improve breast cancer detection through mammography. He discusses the role of breast arterial calcifications in health, the integration of AI in radiology, and the regulatory and cultural challenges of advancing AI in healthcare. Kevin also highlights leadership, mentorship, education, and strategies for growing a successful healthcare technology company, as well as the evolving opportunities AI brings to women’s health and healthcare professionals. Chapters: 00:00 Introduction to AI in Healthcare 03:49 The Genesis of CureMetrix 09:10 Challenges in Mammography 14:58 Innovations in Breast Cancer Detection 21:10 Leadership and Team Dynamics at CureMetrix 26:19 Building a Professional Culture 27:37 Challenges in AI Adoption 31:24 Navigating Regulatory Hurdles 34:40 Sales Strategies in a Niche Market 39:02 AI's Role in Women's Healthcare 42:04 Opportunities in Healthcare Careers Guest Information:Guest's Name: Kevin HarrisGuest's Title/Position: President and co-founder Guest's Linkedin: https://www.linkedin.com/in/kevindavidharris/Company / Affiliation: CureMetrix https://curemetrix.com/Guest's Bio: Kevin Harris is the President and co-founder of CureMetrix. With over 25 years of leadership experience, Harris brings a demonstrated track record of success with particular expertise in new product ideation, implementation, market creation, and launch. As a strategic leader with deep operational expertise, Harris has led companies from inception through fundraising and mergers and acquisitions.  At CureMetrix, Harris is responsible for envisioning the AI-based products and services tied to breast cancer and breast arterial calcifications detection that are the foundation of the company’s business and are the first of their kind in the world. Takeaways:Kevin Harris has over 35 years of experience in technology.CureMetrix was founded to leverage AI in healthcare.The company focuses on improving mammography outcomes.Breast arterial calcifications can indicate serious health issues.AI can help reduce false positives in mammography.CureMetrix's software provides valuable insights to radiologists.Collaboration with data scientists is crucial for innovation.Building a strong team and mentorship is key to success.Understanding the healthcare landscape is essential for leaders.Patient outcomes can be significantly improved with AI. Building a company culture of professionalism reduces drama.AI is perceived as a tool rather than a replacement for doctors.AI operates consistently without human limitations.Regulatory challenges are significant in bringing AI to market.Sales strategies must target the right decision-makers in healthcare.Education is crucial for the adoption of AI in healthcare.AI can help radiologists focus on more critical cases.There are opportunities to automate certain healthcare tasks safely.AI can assist in pre-reading medical images to save time.The healthcare system needs to improve public education on health issues.

In this episode of The Healthy Enterprise, Anna Forsythe, founder and CEO of Oncoscope-AI, shares her journey from manually processing oncology data to creating an AI-powered platform that delivers real-time treatment insights, clinical guidelines, and research to support oncologists in an ever-evolving cancer landscape. She discusses the importance of reliable evidence in decision-making, the positive response from physicians using the free platform, and the role of systematic data reviews in building trust and efficiency. Beyond the technology, Anna reflects on her entrepreneurial path, the challenges and opportunities of leading in healthcare, and the importance of cultivating talent, mission-driven culture, and visionary leadership. The conversation concludes with her insights on business models, community impact, and the future of AI in advancing cancer care. Chapters:00:00 Introduction to Oncoscope-AI and Anna Forsythe03:04 The Need for Real-Time Oncology Data05:59 Transitioning from Manual to Automated Data Processing09:11 The Role of AI in Oncology12:13 Feedback and Response from Healthcare Professionals14:45 Data Sources and Systematic Reviews in Oncology18:02 Future Developments and Expanding Services21:53 AI in Research: Balancing Trust and Efficiency25:52 Business Model and Revenue Streams29:44 Personal Journey and Altruism in Business32:56 Challenges and Opportunities in Healthcare35:34 Leadership and Team Dynamics39:29 Visionary Leadership and Future Aspirations Guest Information:Guest's Name: Anna ForsytheGuest's Title/Position: Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/anna-forsythe-3667143/ Company / Affiliation:  Oncoscope-AI https://oncoscope-ai.com/ Guest's Bio: Anna Forsythe, PharmD, MBA, is the Founder and CEO of Oncoscope-AI, the first platform to unify real-time oncology treatment data, clinical guidelines, research, and regulatory approvals—offered free to oncology professionals worldwide and often described as “Expedia for cancer care.” With a background spanning pharmacy, health economics, and executive leadership at Novartis, Bayer, and Eisai, Anna previously co-founded Purple Squirrel Economics (acquired by Cytel in 2020), has taught health economics at Long Island University, and is a frequent industry speaker and author, with her 2022 JAMA Pediatrics article on conversion therapy ranked in the top 5% of all JAMA research outputs worldwide. Takeaways:Anna Forsythe is the founder and CEO of Oncoscope AI.Oncoscope AI provides real-time oncology treatment data and clinical guidelines.Doctors are overwhelmed with the volume of new evidence and guidelines.The platform aims to simplify access to oncology data, similar to Expedia for travel.AI is used to automate data processing but has limitations in consistency and accuracy.The platform is currently free for doctors to encourage adoption.Feedback from healthcare professionals is shaping the development of the platform.Data is sourced from publicly available databases like PubMed and clinical trials.The platform is expanding to include more cancer types and features.The response from users has been overwhelmingly positive, with over a thousand sign-ups. AI has a 0.2% error rate, necessitating careful review.A standardized database enhances research efficiency.The business model aims for profit while providing value.Personal experiences shape the desire to help others.Gathering data from doctors can lead to significant advertising revenue.The speaker is focused on launching multiple cancer treatments.Trust and transparency are crucial in AI innovation.Working with young talent is fulfilling and beneficial.Challenges in scaling the business are common in startups.Visionary leadership requires prioritization and focus.

In this episode, Sarah Bellenger, nurse veteran and entrepreneur, shares her journey creating Manage You, an app designed to fix inefficiencies in healthcare credentialing. She discusses the challenges of launching tech in a traditional industry, overcoming skepticism, and the importance of innovation and female leadership in healthcare. Sarah also reflects on funding disparities for women entrepreneurs and her vision for Manage You’s future impact on the industry. Chapters00:00 Introduction to Sarah Bellenger and Manage You03:07 The Need for Credentialing Solutions05:53 The Development Journey of Manage You08:48 Challenges in Healthcare Credentialing12:06 The App's Features and User Experience14:58 Expanding Manage You's Reach18:03 Future Developments and Scalability20:58 Entrepreneurial Insights and Challenges23:51 The Role of Women in Entrepreneurship26:47 Vision for the Future of Credentialing30:00 Conclusion and Call to Action Guest Information:Guest's Name: Sarah BellengerGuest's Title/Position: Founder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/sarahrbellenger/Company / Affiliation: Manage You App https://www.manageyouapp.com/Guest's Bio: Sarah Bellenger is a clinician, Army veteran, and healthcare leader with over two decades of experience in patient care, team leadership, and system-wide operations. Her career spans cardiac ICU nursing, managing anesthesia teams across the U.S. and abroad, and even supporting executive health at the White House. After earning her MBA and serving in multiple leadership roles, Sarah recognized a recurring problem: capable professionals were burning out—not from the work itself, but from the inefficiencies surrounding it. Driven by her own experiences, including losing critical credentials during frequent relocations, Sarah founded Manage You—a mobile app that helps healthcare professionals and teams centralize documents, track deadlines, and simplify renewals. Her mission is clear: to reduce administrative burdens so clinicians can focus on what matters most—caring for patients.Takeaways:Sarah Bellenger is a nurse veteran and entrepreneur.Manage You addresses the inefficiencies in the credentialing process.Credentialing is a $39 billion industry with significant waste.The app allows users to store and manage their credentials efficiently.Users receive reminders for expiring documents directly on their phones.The app is designed to be user-friendly and secure.Sarah emphasizes the importance of networking and mentorship in entrepreneurship.Women face unique challenges in securing venture capital funding.The future of credentialing may involve digital verification and AI.Sarah is committed to making healthcare credentialing more efficient.

In this episode of The Healthy Enterprise, host Heath talks with Erin Morrow, Director of Product Management at Embark Veterinary, about how genetics and AI are transforming pet health. Erin shares her journey into product management, the role of dog DNA in better care decisions, and the challenges of building products in a fast-moving startup. She also dives into the integration of AI at work, the power of customer feedback, and creative marketing strategies—including collaborations with Disney. The conversation wraps with advice for aspiring professionals and a look at the future of technology in pet care. Chapters: 00:00 Introduction to Embark Veterinary and Its Mission 03:04 Erin Morrow's Journey and Background 05:57 Understanding Dog DNA and Its Impact on Care 09:03 The Role of Technology in Pet Care 12:00 Future Innovations in Pet Health and AI 14:59 Challenges in Product Development and Strategy 17:55 The Value of Fractional Leadership 20:49 Customer Feedback and Engagement Strategies 26:49 Embracing AI in the Workplace 30:12 Navigating Marketing Strategies 38:41 Innovative Collaborations in Pet Care 43:50 Advice for Aspiring Professionals Guest Information:Guest's Name: Erin Morrow Guest's Title/Position: Director of Product ManagementGuest's Linkedin: https://www.linkedin.com/in/erin-morrow-68336829/Company / Affiliation: Embark Veterinary https://embarkvet.com/Guest's Bio: Erin Morrow is the Director of Product at Embark Veterinary, where she combines her passion for animals with cutting-edge technology to revolutionize pet care. With over 15 years of experience, she specializes in taking innovative products from initial concept through commercialization across SaaS, biotech, and educational technology sectors. Erin has a proven track record of building high-performing teams that consistently deliver products that users genuinely love. Her unique background includes a Bachelor's in Animal Science and Master's in Conservation Biology, giving her both the scientific rigor and deep empathy for animals and their caretakers that drives her customer-focused approach to product development. Takeaways:Embark Veterinary focuses on using genetics to enhance dog health.Erin Morrow has a diverse background in product management and animal science.Understanding a dog's DNA can significantly impact care decisions.The company has tested over 2 million dogs worldwide.AI and genomics are key to future pet health innovations.Customer feedback is crucial for product development.Fractional leadership can provide valuable insights and direction.Engaging with customers through social media enhances feedback.The importance of transitioning to a product-led organization.Continuous improvement in product offerings is essential for growth. We're starting to use AI internally and for customer-facing features.If you're writing an email, use ChatGPT for assistance.You still need to check your work; you are the subject matter expert.Finding the right tools is complex; experiment with different options.Word of mouth is still our strongest marketing engine.We collaborated with Colossus for our commercials.Our partnership with Disney was a significant campaign.We track brand awareness through customer feedback.Collaborations in the pet care space are yielding positive results.Follow your passion, but stay open-minded in your career. 

In this episode, Dr. Harsha Rajasimha discusses his journey as a biotech entrepreneur and the founder of Jeeva Clinical Trials. He shares insights into the inefficiencies of traditional clinical trials and how AI can streamline the process, making it more efficient and accessible. The conversation also touches on the importance of inclusivity in clinical research, the role of AI agents, and the personal motivations behind his work. Dr. Rajasimha emphasizes the need for a unified platform to enhance collaboration and reduce complexity in clinical trials, ultimately aiming to improve patient outcomes. Chapters:00:00 Introduction to Jiva Clinical Trials and Harsha Rajaseema02:50 The Clinical Trial Process: Challenges and Innovations05:51 AI in Clinical Trials: Enhancing Efficiency and Security08:59 The Role of AI Agents in Clinical Research11:55 Addressing Inequities in Clinical Trials15:02 Philanthropy and Patient Advocacy in Rare Diseases18:08 The Journey of an Entrepreneur: Insights and Advice Guest Information:Guest's Name: Dr. Harsha K. RajasimhaGuest's Title/Position: Founder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/harsharajasimha/Company / Affiliation: Jeeva Clinical Trials https://jeevatrials.com/Guest's Bio: Dr. Harsha K. Rajasimha is a scientist, entrepreneur, and patient advocate, and the Founder & CEO of Jeeva Clinical Trials—an AI-driven platform making clinical research more efficient and accessible worldwide. He also serves as Founder and Chair of the Indo US Organization for Rare Diseases, building global collaboration to improve outcomes for patients with rare conditions. Motivated by personal loss, Harsha has dedicated his 20-year career in precision medicine and biotech to advancing rare disease research, patient advocacy, and the use of technology to accelerate clinical trials.Takeaways:Dr. Harsha Rajasimha is the founder of Jeeva Clinical Trials.Clinical trials typically take 8-10 years to complete.AI can significantly reduce the time and cost of clinical trials.The current clinical trial infrastructure is complex and fragmented.Jeeva aims to unify the clinical trial process with a single platform.AI agents will automate repetitive tasks in clinical trials.Inclusivity in clinical trials is crucial for diverse patient representation.Philanthropy plays a key role in Dr. Rajasimha's mission.The platform supports over 100 languages for global accessibility.Community support is essential for entrepreneurial success.

In this episode, Bill Wittmeyer discusses his journey as the CEO of Maggie's Breath, a company focused on using breath analysis for early detection of breast cancer. He shares insights into the technology behind breath analysis, the importance of early detection, and the challenges faced in the healthcare industry. Bill also reflects on the personal impact of breast cancer in his life and the future plans for Maggie's Breath, including clinical trials and funding efforts. Chapters: 00:00 Introduction to Bill Wittmeyer and Maggie's Breath 03:04 The Journey to Breath Analysis Technology 05:55 The Importance of Early Detection in Breast Cancer 08:56 Innovative Screening Methods and Their Implications 11:49 The Role of Metabolic Compounds in Disease Detection 15:05 Challenges in Implementing New Screening Technologies 18:01 Mobile Screening Solutions for Breast Cancer 20:59 Future Directions and Global Health Implications 26:55 Clinical Trials and Market Opportunities 30:02 Innovative Screening Technologies 34:04 Navigating Regulatory Challenges 36:10 The Journey of a Startup Founder 41:45 Personal Loss and Legacy 49:30 Fundraising and Community Engagement Guest Information:Guest's Name: Bill WittmeyerGuest's Title/Position: Founder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/bill-wittmeyer-b0628a/Company / Affiliation: Maggie's Breath https://www.maggiesbreath.com/ Guest's Bio: Bill Wittmeyer is the Founder and CEO of Maggie’s Breath (formerly Pulmostics Limited) where he applies advanced detection technologies—such as high-speed gas chromatography—to protect human health and the environment. Maggie’s Breath was renamed in honour of Bill’s late wife, Maggie, who lost her battle with breast cancer while working to advance life-saving diagnostics. Her vision lives on through the company’s mission: to create a revolutionary, non-invasive breath-based screening tool that can detect disease early and save lives. Bill’s leadership spans innovations in healthcare, environmental monitoring, and public safety, all driven by a commitment to turning personal loss into global impact for a healthier, more sustainable world.Takeaways: -Bill Wittmeyer is the CEO of Maggie's Breath, focused on breath analysis for breast cancer detection. -Maggie's Breath aims to provide a non-invasive screening tool for breast cancer. -The technology can analyze breath samples in just one minute. -Breast cancer is increasingly affecting younger women, necessitating early detection methods. -Current mammogram practices may not be effective for women with dense breast tissue. -Breath analysis could complement existing mammogram technologies. -The goal is to provide diagnostically actionable information at the point of care. -Maggie's Breath was named in honor of Bill's late wife, who passed away from breast cancer. -The company is seeking funding and partnerships to conduct clinical trials in Mexico. -Bill emphasizes the importance of early detection in improving survival rates and reducing treatment costs. 

In this episode, Dr. Steve Schutzer shares his journey from a Bronx kid to a prominent orthopedic surgeon and co-founder of Upswing Health. He discusses the importance of improving patient experiences in healthcare, the challenges faced in the industry, and the innovative solutions Upswing Health offers to streamline orthopedic care. The conversation highlights the significance of direct primary care, functional medicine, and the need for interoperability in healthcare systems. Dr. Schutzer emphasizes the entrepreneurial spirit required to address healthcare challenges and the importance of mentorship and effective communication in achieving success. Chapters:00:00 Introduction to Dr. Steve Schutzer and Upswing Health02:49 Dr. Schutzer's Journey in Medicine06:02 Mentorship and the Impact of Innovation in Orthopedics08:51 Creating Centers of Excellence in Joint Replacement11:55 Challenges in Healthcare and the Role of Legislation14:50 Direct Pay and Direct Primary Care Innovations18:01 Functional Medicine and Preventative Healthcare21:06 The Future of Healthcare and Entrepreneurial Medicine31:39 The Shift to Entrepreneurship32:25 Building Centers of Excellence34:48 Identifying the Ouch Moment36:12 Innovative Solutions in Orthopedics39:11 The Evolution of Orthopedic Management41:28 The Vision for Upswing44:20 Navigating Healthcare Challenges47:30 Interoperability in Healthcare51:27 The Future of Upswing55:45 The Role of Employers in Healthcare58:42 Marketing Strategies for Upswing Guest Information:Guest's Name: Steve Schutzer Guest's Title/Position: Co-Founder and Chief Medical Officer Guest's Linkedin: https://www.linkedin.com/in/steve-schutzer-md-81616125/Company / Affiliation: Upswing Health https://upswinghealth.com/Guest's Bio: Steve Schutzer is an orthopedic surgeon specializing in adult hip and knee reconstruction, with decades of experience leading joint replacement programs and advancing value-based orthopedic care. He believes in the power of connected communities and digital technologies—especially in today’s accelerating AI environment—working alongside compassionate human caregivers to solve complex medical challenges. Recognized as a focused, innovative, and visionary healthcare physician leader and strategist, Steve has an enduring obsession with improving the patient experience.Takeaways:Dr. Schutzer's journey reflects the unpredictability of career paths.The importance of mentorship in shaping a physician's career.Building centers of excellence can significantly improve patient care.Healthcare challenges are often rooted in financial disincentives.Direct primary care offers a promising alternative to traditional models.Functional medicine focuses on prevention and holistic care.Upswing Health aims to provide quick access to orthopedic care.Interoperability in healthcare is crucial for better patient outcomes.The rise of early onset cancers highlights the need for preventive care.Entrepreneurship in healthcare requires resilience and adaptability.

In this episode of The Healthy Enterprise, Jessicca Rege shares her groundbreaking work in cancer research at Sus Clinicals, where her team uses genetically modified “Oncopigs” to bridge the gap between preclinical and clinical trials. She discusses her path from academia to industry, her dual role as Chief Medical Officer at OncoScope AI, and her commitment to pushing the boundaries of oncology through innovative research, AI integration, and precision medicine. Jessicca also opens up about overcoming imposter syndrome, navigating the challenges of being a female leader, and mentoring the next generation of women in science. The conversation explores Sus Clinicals’ growth strategies in large animal research and offers inspiring insights for aspiring leaders on resilience, vision, and questioning the status quo. Chapters:00:00 Introduction to Jessicca Rege and Sus Clinicals07:30 The Oncopig Model: Revolutionizing Cancer Research18:04 The Journey of a Mutant Pig Farmer24:51 AI in Cancer Research and Future Directions27:14 Introduction to OncoScope AI and Leadership Roles28:36 Disruptive Leadership and Questioning the Status Quo30:45 Navigating Imposter Syndrome as a CEO32:42 The Challenges of Being a Female Leader35:41 Cultivating Future Female Leaders39:03 Steering Growth at Sus Clinicals41:33 Innovative Approaches in Large Animal Research45:34 Future Outlook and Goals for Sus Clinicals49:25 Advice for Aspiring Leaders Guest Information:Guest's Name: Jessicca RegeGuest's Title/Position: Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/jessiccarege/Company / Affiliation: Sus Clinicals https://susclinicals.com/Guest's Bio: Jessicca Rege is a pharmaceutical executive with extensive experience in oncology drug development, from pre-IND through commercialization. She has led R&D, regulatory, and medical affairs teams in both large pharma and biotech, guided in-licensing and acquisition strategies, and worked closely with global regulatory authorities. Jessica is also a trusted voice with investors, scientific leaders, and industry partners, advancing innovative cancer therapies worldwide. Takeaways:Jessicca Rege is passionate about transformative research in cancer.Sus Clinicals uses genetically modified pigs to advance cancer research.The Oncopig model allows for testing efficacy, safety, and metabolic effects.Cancer patients are often more knowledgeable about their conditions than expected.Jessica emphasizes the importance of empathy in patient care.The Oncopig model can replicate human cancers on demand.Precision medicine is becoming the standard in oncology.AI is being utilized in cancer research for systematic literature reviews.Jessica's journey reflects a commitment to improving patient outcomes.The integration of various medical professionals is crucial in cancer treatment. I am known as a disruptive leader.Imposter syndrome is always going to be with us.We want to continue to build models that enable researchers.We have a hundred percent success rate in being able to induce tumors.We believe the uptake is coming in.We could sell each of our different models to a different CRO.We hope to become a profitable company by 2027.You get more nos than you get yeses.I love the impact that I'm making on the teams.

In this episode, Braden Pan, CEO and founder of Resolve, discusses the significant issue of medical debt in America, which affects one in three individuals and is a leading cause of bankruptcy. He shares his personal journey that led him to create Resolve, a company dedicated to helping patients navigate and reduce their medical bills. Braden elaborates on the challenges of founding a startup, the integration of AI in their processes, and the importance of negotiating with hospitals. He also emphasizes the need for co-founders and the evolution of his leadership style as the company grows. The conversation highlights the future of Resolve, focusing on B2B expansion and the broader goal of addressing various types of debt. Chapters: 00:00 Introduction to Resolve and Medical Debt 03:11 Braden's Personal Journey and Founding Resolve 06:11 Navigating the Complexities of Medical Billing 09:05 The Role of AI in Medical Billing Solutions 12:05 Understanding Hospital Billing Practices 14:47 The Impact of Medical Debt on Patients 17:58 Marketing Strategies and Patient Success Stories 20:53 Future Directions for Resolve 22:37 Navigating Financial Aid in Healthcare 25:22 The Role of a Founder and CEO 30:40 Shifting Business Strategies and Messaging 32:14 Future Aspirations and Goals 35:25 Leadership Evolution and Team Dynamics 39:34 Advice for Aspiring Founders and Co-founders Guest Information:Guest's Name: Braden PanGuest's Title/Position: CEO and FounderGuest's Linkedin: https://www.linkedin.com/in/bradenpan/Company / Affiliation: Resolve https://www.resolvemedicalbills.com/Guest's Bio: The idea for Resolve was sparked in 2016, when founder Braden Pan received an outrageous hospital bill for a brief, 15-minute consultation. Frustrated by the complex and opaque billing process, Braden set out to find a better way. That experience became the foundation for Resolve—a company dedicated to helping Americans fight back against unfair medical bills. Since then, Resolve has tackled all types of healthcare billing challenges, partnering with experts across the healthcare ecosystem to reduce financial stress and bring greater transparency to the system.Takeaways:Medical debt is a massive issue affecting many Americans.Resolve has saved patients over $55 million on medical bills.Braden's personal experience with medical debt inspired him to start Resolve.The healthcare system is complex and often designed to confuse patients.AI is being integrated into Resolve's processes to improve efficiency.Hospitals often prefer working with Resolve to lower their collection costs.Financial aid programs exist but are underutilized by patients.Braden emphasizes the importance of having a co-founder.Leadership evolves over time, especially in a startup environment.The future of Resolve includes expanding services to address all types of debt.

In this episode we will meet with Stephanie Dorwart, CEO of Altius Healthcare Consulting Group, for a wide-ranging conversation about how healthcare is changing—and what leaders need to do to keep up. We talk about the long-term impact of COVID-19, the growing role of data in driving smarter operations, and why strong, accountable leadership matters more than ever. Stephanie also shares her own journey from math teacher to healthcare CEO, and offers insights on the future of the industry—from the rise of telehealth to the unique challenges facing rural health systems. Chapters: 00:00 Introduction to Altius Healthcare Consulting 02:46 Stephanie's Journey into Healthcare 06:50 Impact of COVID-19 on Healthcare Innovation 10:32 The Role of Data in Healthcare 12:02 Empowering Leaders through Data 14:28 Building Trust and Accountability in Leadership 18:13 The Importance of Continuous Improvement in Healthcare 22:31 Navigating Leadership Development 30:12 The Entrepreneurial Leap 37:59 Innovations in Healthcare 41:14 Vision for the Future of Altius Guest Information: Guest's Name: Stephanie Dorwart Guest's Title/Position: Chief Executive Officer Guest's Linkedin: https://www.linkedin.com/in/stephanie-dorwart/ Company/Affiliation: Altius Healthcare Consulting Group https://altiushcg.com/ Guest's Bio: Stephanie Dorwart is the CEO of ALTIUS, a healthcare consulting firm she rebranded and now leads with a hands-on, results-driven approach. With over 15 years of experience in performance improvement and labor management, she’s worked with hospitals of all sizes—from rural facilities to large academic medical centers—helping them improve financial performance, patient outcomes, and staff satisfaction. Known for her analytical expertise and deep industry insight, Stephanie consistently delivers measurable ROI and lasting client impact. Takeaways:Altius focuses on improving financial and operational performance in healthcare.Stephanie transitioned from teaching to healthcare due to a passion for data and patient care.COVID-19 accelerated the adoption of telehealth and innovative care models.Data in healthcare is relatively new and can significantly impact productivity.Empowering leaders with data helps them make informed decisions.Building trust within teams is essential for effective leadership.Accountability starts with setting clear goals and regular check-ins.Time management is crucial for leaders to think strategically.Rural healthcare systems face unique challenges and need support.The future of healthcare may focus more on preventive care and nutrition.

In this episode of The Healthy Enterprise as we dive into the world of sustainable innovation with Yuliana Mihaylova, a biotech executive and co-founder of OliveBio. Discover how Yuliana's journey from a PhD in genetics to an entrepreneur is paving the way for eco-friendly alternatives to petrochemical plastics. Learn about the challenges and triumphs of creating scalable bioplastics and the role of AI in revolutionizing production processes. Chapters: 00:14 Introduction to OliveBio and Yuliana's Background 02:01 The Motivation Behind OliveBio: Tackling Plastic Pollution 06:15 Understanding PHAs: A Sustainable Bioplastic Solution 11:59 OliveBio's Innovative Production Process for PHAs 15:57 Applications and Future of Bioplastics 18:21 Yuliana's Entrepreneurial Journey and Challenges 22:36 Leveraging AI and Automation in Biotech 33:13 Marketing and Growth Strategy for OliveBio 36:49 Vision for OliveBio's Future Impact 39:43 Key Learnings and Advice for Aspiring Innovators Guest Information:Guest's Name: Yuliana MihaylovaGuest's Title/Position: CEO & Co-FounderGuest's Linkedin: https://www.linkedin.com/in/yulianamihaylova/Company / Affiliation: OliveBio https://olivebio.com/Guest's Bio: Yuliana Mihaylova is a seasoned biotech executive and the team’s mission enforcer. After completing her Genetics PhD and post-doctoral research at the universities of Nottingham and Oxford, respectively, she worked in biotech and pharma management consulting, where she helped companies develop their asset commercialization and market access strategies. From 2019 to 2024, Yuliana was part of the executive team at Basepaws, a pet genetics company, acquired by the animal pharma startup Zoetis in 2022. As Basepaws’ Head of R&D, she led the development and refinement of new technologies and scientific products and was a key stakeholder in the translation of scientific discovery into business strategy. Yuliana believes strongly in the power of cross-disciplinary collaboration and innovative thinking to solve the world’s most pressing environmental challenges. Takeaways:OliveBio, co-founded by Yuliana Mihaylova, is developing scalable, affordable bioplastics to combat plastic pollutionFocuses on PHAs, biodegradable polymers from renewable sources that leave no microplasticsUses enzyme-based production instead of bacterial fermentation for better precision and lower costsPHAs have broad applications: packaging, single-use items, agriculture, 3D printing, and medical uses like suturesYuliana’s entrepreneurial journey includes adapting quickly, embracing failure, and bootstrapping with limited resourcesAI is integrated into OliveBio’s production systems and daily operations to enhance efficiency and accuracyMarketing strategy targets B2B2C—engaging businesses and influencing consumer demandLong-term vision is to build a sustainable, impactful company rather than seeking early acquisition